Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
---|
02/16/2006 | US20060035359 Survivin-binding proteins, encoding nucleic acids, and methods of use |
02/16/2006 | US20060035334 Apo-2 receptor |
02/16/2006 | US20060035331 G-protein coupled receptors |
02/16/2006 | US20060035330 Non aggregating fluorescent proteins and methods for using the same |
02/16/2006 | US20060035328 Artery-and vein-specific proteins and uses therefor |
02/16/2006 | US20060035326 Genes |
02/16/2006 | US20060035321 Hydantoin racemase |
02/16/2006 | US20060035320 Immunoglobulin frameworks which demonstrate enhanced statbility in the intracellular envioronment and methods of identifying same |
02/16/2006 | US20060035318 Teneurin c-terminal associated peptides (tcap) and uses thereof |
02/16/2006 | US20060035315 Transporters and ion channels |
02/16/2006 | US20060035305 Synthetic peptides, conjugation reagents and methods |
02/16/2006 | US20060035303 JNK3 modulators and methods of use |
02/16/2006 | US20060035293 Antibodies, polypeptides and polynucleotides, used for detection, prevention and treatment of diseases caused by gramnegative bacteria |
02/16/2006 | US20060035290 Isolation of endothelial progenitor cell subsets and methods for their use |
02/16/2006 | US20060035286 Monitor protein for measuring processing of protein |
02/16/2006 | US20060035284 Methods for isolating molecular mimetics of unique Neisseria meningitidis serogroup B epitopes |
02/16/2006 | US20060035272 Compositions and methods for use in isolation of nucleic acid molecules |
02/16/2006 | US20060035268 Methods and compositions for identifying morphogenic protein analogs using morphogenic protein responsive inhibitory elements |
02/16/2006 | US20060035216 recombinant nucleic acid; isotopic, fluorescent, chemiluminescent, enzymatic, or hapten probe; cloning vector of the nucleic acid; host cell with improved exogenous expression of the nucleic acid; biodegradation; pollution control |
02/16/2006 | US20060035213 POSH nucleic acids, polypeptides and related methods |
02/16/2006 | US20060034955 Useful in increasing the effects of nucleic acid vaccines and medicaments; in production of phenotypically immature and/or mature dendritic and/or fibrocyte cells |
02/16/2006 | US20060034864 Compounds, compositions and methods for the endocytic presentation of immunosuppressive factors |
02/16/2006 | US20060034857 Administering an isolated polynucleotide encoding a Notch ligand comprising a Delta Serrate Ligand (DSL) domain to a cell of a patient; the Notch ligand is expressed and interacts with a Notch receptor to reduce T-cell activation; antiallergens; graft rejection; autoimmune disease |
02/16/2006 | US20060034850 Antibodies as T cell receptor mimics, methods of production and uses thereof |
02/16/2006 | US20060034834 Intrabody-mediated control of immune reactions |
02/16/2006 | US20060034830 Immunoglobulins comprising predominantly a GalGlcNAcMan5GLcNAc2 glycoform |
02/16/2006 | US20060034829 Immunoglobulins comprising predominantly a MAN3GLCNAC2 glycoform |
02/16/2006 | US20060034826 contacting an immune cell with an agent that modulates the interaction between PD-1 and a PD-1 ligand (e.g., soluble forms of PD-1 or PD-1 ligand or antibodies to PD-1); inhibits signaling via PD-1 |
02/16/2006 | US20060034813 Expression of proteins in cord blood-derived endothelial cells |
02/16/2006 | US20060034810 Novel artificial antigen presenting cells and uses therefor |
02/16/2006 | US20060034808 Amorphous cell delivery vehicle treated with physical/physicochemical stimuli |
02/16/2006 | US20060034807 Innervated artificial tissues and uses thereof |
02/16/2006 | US20060034802 Procedure for the large-scale t-lymphocytes culture in a homogeneous system |
02/16/2006 | CA2576573A1 Use of pax4 in pancreatic cell proliferation |
02/16/2006 | CA2576415A1 Knockout nonhuman animal |
02/16/2006 | CA2576151A1 Inducible expression systems for modulating the expression of target genes in eukaryotic cells and non-human animals |
02/16/2006 | CA2575989A1 Means and methods for producing a stabilized cell of interest |
02/16/2006 | CA2573656A1 Aav vector compositions and methods for enhanced expression of immunoglobulins using the same |
02/16/2006 | CA2573437A1 Medium for growing human embryonic stem cells |
02/16/2006 | CA2573354A1 Preprimitive streak and mesendoderm cells |
02/16/2006 | CA2573283A1 Methods for identifying factors for differentiating definitive endoderm |
02/16/2006 | CA2573044A1 Novel microfluidic system and method for capturing cells |
02/16/2006 | CA2572326A1 Capsules containing transfected cells, method for preparing the same and uses thereof for immunization and vaccination |
02/15/2006 | EP1626096A2 In vitro method of detecting a cell proliferative disorder involving fibroblast growth factor homologous factor-1 (FHF-1) |
02/15/2006 | EP1626084A1 Compositions and methods for the diagnosis of tumours |
02/15/2006 | EP1626083A1 Substances for preventing and treating autoimmune diseases |
02/15/2006 | EP1626058A1 Compositions and methods for the diagnosis of tumour |
02/15/2006 | EP1626056A2 Methods and compositions relating to modulation of hepatocyte growth, plasma cell differentiation or T cell subset activity by modulation of XBP-1 activity |
02/15/2006 | EP1625796A1 Use of a high-ester pectin in acidic, protein-containing foodstuffs |
02/15/2006 | EP1625222A2 Broadening adenovirus tropism |
02/15/2006 | EP1625213A2 A method for efficient transfer of human blastocyst-derived stem cells (hbs cells) from a feeder-supported to a feeder-free culture system |
02/15/2006 | EP1625212A1 Artificial immune organ |
02/15/2006 | EP1625209A2 Immunoglobulin chimeric monomer-dimer hybrids |
02/15/2006 | EP1625206A2 siRNA INDUCED SYSTEMIC GENE SILENCING IN MAMMALIAN SYSTEMS |
02/15/2006 | EP1625204A2 Genes encoding carotenoid compounds |
02/15/2006 | EP1625203A2 Efficient haploid cell sorting for flow cytometer systems |
02/15/2006 | EP1625164A1 Method of detecting probnp with a monoclonal antibody binding to the amino acids 41-46 |
02/15/2006 | EP1625163A1 Method of detecting probnp with a monoclonal antibody binding to the amino acids 38-44 |
02/15/2006 | EP1625162A2 Compositions and methods for treatment of cryptococcosis |
02/15/2006 | EP1625154A1 Hepatitis c virus ns5b polymerase inhibitor binding pocket |
02/15/2006 | EP1625144A2 Polyvalent immunogen |
02/15/2006 | EP1625141A2 Grp94-based compositions and methods of use thereof |
02/15/2006 | EP1624899A2 Increased transduction using abc transporter substrates and/or inhibitors |
02/15/2006 | EP1624892A2 Therapeutic use of anti-cs1 antibodies |
02/15/2006 | EP1624883A2 Compositions and methods related to production of erythropoietin |
02/15/2006 | EP1624847A2 Compositions and methods for the preparation of human growth hormone glycosylation mutants |
02/15/2006 | EP1624758A2 Hematopoietic stem cells and methods of treatment of neovascular eye diseases therewith |
02/15/2006 | EP1624751A2 Cryopreservation of human blastocyst-derived stem cells by use of a closed straw vitrification method |
02/15/2006 | EP1624748A2 A transgenic animal model for cancer and stem cells |
02/15/2006 | EP1490088A4 Dentritic cell nodes |
02/15/2006 | EP1482787A4 Embryonic-like stem cells derived from post-partum mammalian placenta and uses and methods of treatment using said cells |
02/15/2006 | EP1478304A4 Pre-fabricated tissue-engineered plug |
02/15/2006 | EP1444325A4 Methods and devices for the integrated discovery of cell culture environments |
02/15/2006 | EP1328652B1 Non-human transgenic animal expressing ca-ahr |
02/15/2006 | EP1226236B1 Polypeptides having glucanotransferase activity and nucleic acids encoding same |
02/15/2006 | EP1118664B1 Method for producing choroid plexus immortalized cell lines |
02/15/2006 | EP1065269B1 Genomic gene encoding hm1.24 antigen protein and promoter thereof |
02/15/2006 | EP0871738B1 Viral recombinant pseudo-particles and vaccinal and anti-tumoral applications |
02/15/2006 | EP0795021B1 Retroviral delivery of full length factor viii |
02/15/2006 | EP0791050B1 Vectors for tissue-specific replication |
02/15/2006 | EP0754232B1 Plant lysophosphatidic acid acyltransferases |
02/15/2006 | CN1735690A Thioesterase-related nucleic acid sequences and methods |
02/15/2006 | CN1735689A Bacterial virulence genes |
02/15/2006 | CN1735686A Method for producing ketocarotenoids by cultivating genetically modified organisms |
02/15/2006 | CN1735685A Treatment of tissue with undifferentiated mesenchymal cells |
02/15/2006 | CN1735684A P153 and P156 antigens for the immunodiagnosis of canine and human ehrlichioses and uses thereof |
02/15/2006 | CN1735346A Cell separation compositions methods |
02/15/2006 | CN1733924A A method for regulating plant lignin content |
02/15/2006 | CN1733923A Method for regulating plant lignin content |
02/15/2006 | CN1733910A Mononal antibody against avermectin, hybridoma cell line secreting the same and its preparation method |
02/15/2006 | CN1733909A Highly effective merge method for animal somatic nucleus transplantation |
02/15/2006 | CN1733908A Abalone triploid pharmaceutical induction method |
02/15/2006 | CN1733907A Method for cloning buffalo somatic cell |
02/15/2006 | CN1733906A Medium for improving quantity and quality of conifer somatic embryogenesis |
02/15/2006 | CN1733905A Culture medium for improving conifer embryogenic callus quality |
02/15/2006 | CN1733904A Method for obtaining conifer embryoid through liquid culture and its culture medium |
02/15/2006 | CN1733903A Method for obtaining conifer embryoid through solid culture and its culture medium |
02/15/2006 | CN1733802A Plant DREB transcription factor and its coding gene and uses |
02/15/2006 | CN1733800A Outer surface proteins, their genes, and their use |
02/15/2006 | CN1732758A Method for establishing high frequency regenerating system of perennial ryegrass |